Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. - Wikidata - wikimedia - TriplyDB

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

http://www.wikidata.org/entity/Q33296950

about

Mutation Profile of Well-Differentiated Thyroid Cancer in Asians Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma RAS mutations in thyroid cancer Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer.The BRAF(V600E) mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?Somatic mutations in solid tumors: a spectrum at the service of diagnostic armamentarium or an indecipherable puzzle? The morphological eyes looking for BRAF and somatic molecular detections on cyto-histological samples BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours.A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma Personalized medicine: the future is not what it used to be.Prognostic utility of BRAF mutation in papillary thyroid cancer.New developments in the treatment of metastatic melanoma - role of dabrafenib-trametinib combination therapy Occult thyroid carcinoma Association between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and without Hashimoto's Thyroiditis The prognostic implication and potential role of BRAF mutation in the decision to perform elective neck dissection for thyroid cancer Clinicopathological features of rare BRAF mutations in Korean thyroid cancer patients Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital.Old and new insights in the treatment of thyroid carcinoma.Langerhans cell histiocytosis of the thyroid with multiple cervical lymph node involvement accompanying metastatic thyroid papillary carcinoma.Associations of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma.High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma BRAF mutation correlates with recurrent papillary thyroid carcinoma in Chinese patients Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600)Thyroid cancer gender disparity.Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma Detection of plasma BRAF(V600E) mutation is associated with lung metastasis in papillary thyroid carcinomas.BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis The utility of BRAF testing in the management of papillary thyroid cancer.BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review Managing thyroid microcarcinomas BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis.BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma.Clinical significance of BRAF V600E mutation in 154 patients with thyroid nodules.BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma.BRAF mutations in thyroid tumors from an ethnically diverse group Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.BRAF mutation in papillary thyroid carcinoma BRAF pyrosequencing analysis aided by a lookup table.

P2860

Q26782322-CD8FE474-13F8-4E48-AE94-603152BE48B7 Q26853261-2A0B0464-EB24-44F2-B4DF-EDF2A04C6C8A Q27026163-A4786E22-0147-4EC6-A53F-1D9ACA3161E7 Q27851648-6787FAB3-A2BD-4BC5-AD19-756F0B205B0F Q27852737-9B2EDAFE-FA4B-414B-8531-5BEF7EC5B0CC Q28070226-762D79AC-7113-4F80-B429-628E7C8E5B74 Q28075975-AA6B5B8B-DDB5-483C-807B-C003D0759F8C Q28274899-30E84611-E076-47A2-B44E-5E2D6C3F9DEA Q33630865-404FEAE4-CDB0-4006-B87B-AAE28A79921E Q33656624-ABCEC3F8-3BD7-4D56-A902-4FED09FD562E Q33750281-5E6C47CB-A1DD-461B-BE48-7296BC39BBED Q33771120-526A88FA-041E-4B00-9E20-CE7F8A5B975F Q33824552-C1306557-C808-4FAC-92B7-1E66A9CF3616 Q33844111-36C79315-FAD3-41E9-8B5A-CFC72203D6BC Q33884794-69E1578E-0495-430B-BBD9-53BDF4493573 Q33973118-061E2087-B29C-4666-87B2-C8A57DA4BCDD Q34029917-D07C64A6-82FC-447E-9A2C-4DFB88CF3531 Q34041618-8CF68083-0372-404E-8C6F-24E0EB7740E6 Q34209934-D0D74D01-B425-4733-871B-A8A11306A898 Q34366295-582309AC-B095-410C-83C6-D3D2A36437DC Q34388349-6AEE451F-0203-4D2A-8011-68CD33655390 Q34572289-E8440822-EF63-4E09-ADEC-593B607FB265 Q34588501-F3140B6F-09B2-4F8E-A4C9-DA6BB5FBAD04 Q34637861-5B28F360-9671-42F9-894D-4E5E03895460 Q34650871-E1EADDBC-BB80-475E-A315-10B38F9CA5AE Q34802748-0634DCD1-4410-4D91-9745-2380273AC1F1 Q35145064-77E57095-3D6D-426F-BB59-4AFE47FCDC77 Q35421479-162B9DE9-1094-46C3-A9C7-C83D31160D86 Q35543644-54780A10-8089-4BE3-8AEF-F065FD60AB02 Q35583821-1CBE4318-E5F5-49ED-84FA-8F05CD815AAF Q35609167-20A10DFB-75FD-49CE-853A-3058A7FBAF33 Q35648278-1AF53142-23AA-4C09-B67F-009AE4805F87 Q35724853-442D645A-8E62-41F2-8150-12A6F06B1C1B Q35755353-5B1F41B3-1930-432B-9581-96E809D1ED2B Q35758471-FB1F8B6C-2DC1-4FB6-807D-C79B2BD18797 Q35857363-C98E8B9F-51B0-40C7-B984-6B2E48D1CCCD Q36209491-B7B91EDC-FEC0-4A1A-A87D-D4F7392917A2 Q36217960-C8CAEB8B-2CF5-41E4-AB13-D7628C19A07C Q36238518-EC7CAB97-9F37-4B0F-8F8B-9C0C837606CA Q36276150-32619A1C-0377-49C8-9282-29C4B0FBFBF1

P2860

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

http://www.wikidata.org/entity/Q33296950

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Association of BRAF V600E muta ...... f papillary thyroid carcinoma.

@ast

Association of BRAF V600E muta ...... f papillary thyroid carcinoma.

@en

type

label

Association of BRAF V600E muta ...... f papillary thyroid carcinoma.

@ast

Association of BRAF V600E muta ...... f papillary thyroid carcinoma.

@en

prefLabel

Association of BRAF V600E muta ...... f papillary thyroid carcinoma.

@ast

Association of BRAF V600E muta ...... f papillary thyroid carcinoma.

@en

P1433

Q33296950-2C14C393-5A04-4D30-A14A-914B4660945E

P1476

Q33296950-AF80B401-E431-4244-ABA7-71F34E4410CE

P2093

Q33296950-05530189-6A14-4927-9714-CEB765A0E425

Q33296950-269A3A89-0C6E-4941-85AB-A64E8D14EACA

Q33296950-48A4945E-5A0E-4549-A063-394D734B21DD

Q33296950-64EF9514-072E-4F46-9776-DC9B488EF831

Q33296950-7E2CE8D0-AD6B-49C8-8213-F56BFBFB0630

Q33296950-E2A66412-A947-4100-A256-5514681D44B7

P304

Q33296950-8D963AA7-93E5-4378-9BA4-F1E68967F538

P31

Q33296950-9032CB53-F8B9-4EB8-9666-46A6DDE7AF1A

P356

Q33296950-5D18C6A2-75D9-4EE4-B39A-6E979ED95066

P407

Q33296950-00A3C29D-40A4-4DAE-B3A4-960DBBDFDA3A

P433

Q33296950-9B4CDDB7-9F6E-4771-9F46-429898896449

P478

Q33296950-E05CA98F-F74D-45C5-BFFA-1EA07FAC4ADD

P50

Q33296950-1D93D5BA-6101-4E2D-B9F1-FB56B211ACFF

Q33296950-6276BE8A-190B-4C64-8A24-5168875E30EF

Q33296950-722F0377-EC7A-4870-8F78-4FFD4648A9B5

Q33296950-8FF19976-BB99-4ECA-A224-1F20C5FE17C0

Q33296950-C81FE43D-2F7B-4903-846B-8D5C78A96B5E

P577

Q33296950-E16006E3-CD49-4339-BCC1-538307ED794B

P698

Q33296950-01922153-4AB6-42EF-9F22-9ACA88D5DF50

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Association of BRAF V600E muta ...... of papillary thyroid carcinoma

@en

P2093

Clara Ugolini

http://www.w3.org/2001/XMLSchema#string

Cristiana Lupi

http://www.w3.org/2001/XMLSchema#string

Gabriele Materazzi

http://www.w3.org/2001/XMLSchema#string

Massimo Santoro

http://www.w3.org/2001/XMLSchema#string

Paolo Miccoli

http://www.w3.org/2001/XMLSchema#string

Piero Berti

http://www.w3.org/2001/XMLSchema#string

P304

4085-4090

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2007-1179

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P50

Michele N Minuto

Riccardo Giannini

Agnese Proietti

Rossella Elisei

P577

2007-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17785355

http://www.w3.org/2001/XMLSchema#string